Lipella Pharmaceuticals Inc. Deferred Revenue, Revenue Recognized
Lipella Pharmaceuticals Inc. (LIPO) reported Deferred Revenue, Revenue Recognized of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-27.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2024-02-27
- Lipella Pharmaceuticals Inc. deferred revenue, revenue recognized for fiscal 2023 was $0.00.
- Lipella Pharmaceuticals Inc. deferred revenue, revenue recognized for fiscal 2022 was $0.00.
- Lipella Pharmaceuticals Inc. deferred revenue, revenue recognized for fiscal 2021 was $0.00.
| Period end | Deferred Revenue, Revenue Recognized 12 month |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-27 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-27 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |